Antiakrasics, commonly known as AAKs, are a class of drugs that provide a profound and prolonged improvement to motivation and executive functions, and are typically used as cognitive performance enhancers. AAKs were initially developed by Pharmatica Group and their Akrasinil brand is their most profitable medication and the most widely sold medication system wide.

Antiakrasics contain a thiazole ring and methy groups which selectively targets neurotransmitters to enhance focus and limit extraneous thoughts. They also contain a benzene ring with an amine group and hydroxyl groups which mimics neurotransmitters like dopamine and serotonin, allowing targeted receptor interaction, and an alkyl chain which aids in crossing the blood-brain barrier. This structure enhances its ability to modulate glutamatergic neurotransmission and increase prefrontal cortex activity.